Invesaro

Stocks Health care BGM

NASDAQ · Health care

BGM Group Ltd. (BGM)

BGM Group Ltd. reported revenue of $37.9M in fiscal 2025, up 51.1% from a year earlier. It posted a net loss of $19.9M. In fiscal 2025 capital spending exceeded operating cash flow by $3.9M. At September 30, 2025 it held $9.8M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on July 21, 2026.

Free, no password. An email when BGM files with the SEC.

Price
$8.01
-2.91% on the day · November 10, 2026
52-week range $6.45 to $291.30
Market cap
$3.2B
Revenue (FY2025)
$37.9M
+51.1% year on year
Net margin
-52.6%

Key facts about BGM Group Ltd.

Net worth
BGM Group Ltd. has a market value (market cap) of $3.2B at the latest share price, and shareholders' equity of $390.9M on its balance sheet at September 30, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $37.9M (+51.1% year on year), with a net loss of $19.9M.
Cash flow
In fiscal 2025 operations used $2.4M of cash.
Latest report
The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on July 21, 2026 and covers the period to September 30, 2025. Open on SEC EDGAR

What BGM Group Ltd. does

BGM Group Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker BGM.

Revenue and profit by year

Revenue
FY18: $50.4M $50.4M FY18FY20: $46.1M $46.1M FY20FY20: $50M $50M FY20FY21: $57.1M $57.1M FY21FY22: $64.9M $64.9M FY22FY23: $46.5M $46.5M FY23FY24: $25.1M $25.1M FY24FY25: $37.9M $37.9M FY25
Net income
FY18: $5.2M $5.2M FY18FY20: $5.9M $5.9M FY20FY20: $5.1M $5.1M FY20FY21: $3.2M $3.2M FY21FY22: $1.1M $1.1M FY22FY23: -$7.8M -$7.8M FY23FY24: -$1.4M -$1.4M FY24FY25: -$19.9M -$19.9M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$37.9M-$12.6M-$19.9M-$0.18-$3.9M
2024$25.1M-$563.8K-$1.4M-$0.20$304.1K
2023$46.5M-$2.6M-$7.8M-$1.08$132.5K
2022$64.9M$2.1M$1.1M$0.15$10.6M
2021$57.1M$2.4M$3.2M$0.45-$1.1M
2020$50M$4.8M$5.1M$0.85$4.6M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where BGM ranks in Health care

Revenue$37.9M
#424 of 751 in Health care · Bottom 44%
Revenue growth+51.1%
#95 of 532 in Health care · Top 18%
Net margin-52.6%
#405 of 544 in Health care · Bottom 26%
Free cash flow margin-10.4%
#294 of 490 in Health care · Bottom 40%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

It paid out $1.8M in cash dividends.

Fiscal yearPer sharePaid outOf profit
2023n/a$1.8Mn/a
2018n/a$733.9K14%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What BGM Group Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 24, 2026
  2. September 8, 2026
  3. August 28, 2026
  4. August 11, 2026
  5. July 30, 2026
  6. July 28, 2026
  7. July 21, 2026
    Annual report (foreign issuer) 20-F · period to September 30, 2025Revenue rose 51% to $37.9M versus the prior year; diluted EPS -$0.18 versus -$0.20.
  8. July 13, 2026
  9. June 17, 2026
  10. June 9, 2026

Recent insider filings (Forms 3, 4 and 144): 5, the latest on May 14, 2026. Insider transactions on SEC

Insider trades

What the people running BGM Group Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns BGM

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Zhanchang Xin13D, may seek influence 38.3% 2,767,800 November 29, 2024
Low Thia Yang13D, may seek influence with 1 related filers 20.7% 38,165,290 May 27, 2025
Zhuojun Feng13G, passive with 1 related filers 16.8% 24,462,500 May 6, 2025
Sihai Ban13G, passive with 1 related filers 10.9% 20,000,000 May 28, 2025
Xing Lai13G, passive with 1 related filers 10.9% 20,000,000 May 28, 2025
Zefei Lou13G, passive with 1 related filers 6% 8,787,500 May 6, 2025

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 12 managers reported a position.

HolderSharesValueChange on quarter
Geode Capital Management, LLC98,472$36.2K+51,511
XTX Topco Ltd63,089$23.2K+51,652
UBS Group AG57,646$21.2K+55,694
Jane Street Group, LLC57,227$21Knew
Susquehanna International Group, Llp32,067$11.8K+16,330
Ground Swell Capital, LLC11,101$4.1Knew
Royal Bank of Canada1,499$1K-507
Jpmorgan Chase & Co1,815$681-168
Morgan Stanley200$740
Virtu Financial LLC54,207$20new
SBI Securities Co., Ltd.9$3+6
Rockefeller Capital Management L.P.5$20

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

No insider reported holdings on a Form 4 in the last 12 months.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about BGM

What does BGM Group Ltd. do?

BGM Group Ltd. is a company in the Health care sector, listed on NASDAQ as BGM. Its shares trade on NASDAQ under the ticker BGM.

What is BGM Group Ltd.'s net worth?

BGM Group Ltd. has a market value (market cap) of $3.2B at the latest share price, and shareholders' equity of $390.9M on its balance sheet at September 30, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is BGM Group Ltd. profitable?

No. In fiscal 2025 it reported a net loss of $19.9M on revenue of $37.9M.

How much revenue does BGM Group Ltd. make?

In fiscal 2025 BGM Group Ltd. reported revenue of $37.9M. That is 51.1% more than a year earlier.

When did BGM Group Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on July 21, 2026. It covers the period to September 30, 2025. Its newest filing of any kind is the foreign issuer update from September 24, 2026.

Similar companies

Compare BGM with

Compare BGM with any company

Follow BGM

Get an email when BGM Group Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when BGM files with the SEC.

Where the numbers come from

Financial figures are the values BGM Group Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.